Open App
you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals

BSE Live

Sep 27, 16:01
904.40 10.60 (1.19%)
Volume
AVERAGE VOLUME
5-Day
7,728
10-Day
31,758
30-Day
16,581
16,960
  • Prev. Close

    893.80

  • Open Price

    893.05

  • Bid Price (Qty.)

    900.00 (13)

  • Offer Price (Qty.)

    904.40 (9)

NSE Live

Sep 27, 16:01
904.95 13.10 (1.47%)
Volume
AVERAGE VOLUME
5-Day
342,822
10-Day
269,508
30-Day
308,342
328,806
  • Prev. Close

    891.85

  • Open Price

    896.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    904.95 (164)

Financials

2021 2020 2019 2018 2017
Profit & Loss account of Ipca Laboratories (in Rs. Cr.) Mar 22 Mar 21 Mar 20 Mar 19 Mar 18  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 5,336.38 5,085.19 4,307.29 3,579.65 3,168.04  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 25.81  
Revenue From Operations [Net] 5,336.38 5,085.19 4,307.29 3,579.65 3,142.23  
Total Operating Revenues 5,399.36 5,139.16 4,367.43 3,633.15 3,193.40  
Other Income 56.13 62.24 64.69 54.59 39.54  
Total Revenue 5,455.49 5,201.40 4,432.12 3,687.74 3,232.94  
EXPENSES  
Cost Of Materials Consumed 1,600.98 1,555.53 1,431.10 1,098.02 923.20  
Purchase Of Stock-In Trade 282.90 197.68 204.65 167.87 168.30  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -120.76 -170.73 -155.05 -106.14 20.98  
Employee Benefit Expenses 1,089.63 948.84 870.79 752.24 712.78  
Finance Costs 7.21 8.14 15.79 18.49 24.02  
Depreciation And Amortisation Expenses 204.10 187.72 178.69 171.88 174.36  
Other Expenses 1,303.07 1,094.26 1,101.18 1,027.99 926.50  
Total Expenses 4,367.13 3,821.44 3,647.15 3,130.35 2,950.14  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,088.36 1,379.96 784.97 557.39 282.80  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 1,088.36 1,379.96 784.97 557.39 282.80  
Tax Expenses-Continued Operations  
Current Tax 197.20 244.98 137.98 119.90 60.01  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 20.14 -5.79 -5.47 -12.40 -9.98  
Tax For Earlier Years 0.08 0.00 0.00 -5.02 -0.34  
Total Tax Expenses 217.42 239.19 132.51 102.48 49.69  
Profit/Loss After Tax And Before ExtraOrdinary Items 870.94 1,140.77 652.46 454.91 233.11  
Profit/Loss From Continuing Operations 870.94 1,140.77 652.46 454.91 233.11  
Profit/Loss For The Period 870.94 1,140.77 652.46 454.91 233.11  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 34.33 90.08 51.64 36.01 18.47  
Diluted EPS (Rs.) 34.33 90.08 51.60 36.01 18.47  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 101.48 101.48 101.08 12.64 12.62  
Tax On Dividend 0.00 0.00 20.77 2.60 2.56  
Equity Dividend Rate (%) 400.00 400.00 250.00 150.00 50.00  
Source : Dion Global Solutions Limited